Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_assertion type Assertion NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_head.
- NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_provenance.
- NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_assertion evidence source_evidence_literature NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_provenance.
- NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_assertion SIO_000772 19318581 NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_provenance.
- NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_assertion wasDerivedFrom befree-2016 NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_provenance.
- NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_assertion wasGeneratedBy ECO_0000203 NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_provenance.